Home|Journals|Articles by Year|Audio Abstracts

Original Article

Pak J Nucl Med. 2014; 4(1): 40-45

99mTc-labelled hepatoiminodiacetic acid (HIDA) scintigraphic evaluation of prevalence of biliary atresia in children with persistent neonatal jaundice: a comparison with national, regional & international studies

Muhammad Inamullah, Mujahid Khalid Ali, Tariq Mahmood Mirza, Muhammad Omair Riaz.


Aims: This retrospective study aimed at determining the prevalence of biliary atresia in children presenting with persistent neonatal jaundice by technetium-99m labelled hepatoimino diacetic acid (99mTc-HIDA) scintigraphy. The results were compared with those from similar studies conducted in Pakistan, South East Asia & internationally. Methods: The study was conducted at Nuclear Medicine Centre, Armed Forces Institute of Pathology, Rawalpindi, from June 2010 to December 2012. A total of 80 patients with persistent neonatal jaundice were included in the study with 54 males & 26 females in a ratio of about 2 to 1. Main outcome measure was demonstration of biliary atresia on technetium-99m labelled hepatoiminodiacetic acid (99mTc-HIDA) scan. Results: Patients with a clinical diagnosis of persistent neonatal jaundice were included in the study. The mean age for males and females at presentation was 224 & 122 days respectively. Biliary atresia was diagnosed in 45 patients with 28 being male and 17 female patients respectively. Conclusion: A significant percentage of patients (56.25%) presenting with persistent neonatal jaundice are found to have biliary atresia on scintigraphic evaluation.

Full-text options

Share this Article

Online Article Submission
• ejmanager.com

ejPort - eJManager.com
Refer & Earn
About BiblioMed
License Information
Terms & Conditions
Privacy Policy
Contact Us

The articles in Bibliomed are open access articles licensed under Creative Commons Attribution 4.0 International License (CC BY), which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/.